IL-6 is an important inflammatory cytokine, and anti-IL-6 receptor or anti-IL-6 antibodies have been approved for the treatment of inflammatory diseases such as rheumatoid arthritis [39]. This evidence concerns the gene IL6 and rheumatoid arthritis.